Mr Mark Feneley

Mr Mark Feneley is a consultant urologist at UCLH, honorary consultant urologist at the Whittington Hospital and honorary associate professor at University College London.

He specialises in urological oncology and treatment of bladder cancer.

Past positions include clinical lead for urology (2008–2009), lead for urological oncology (2003-2006), lead for bladder cancer in the North Thames Cancer Network (2003-2009), lead for undergraduate education in urology (2006-2008) and lead clinical investigator in molecular biology at Prostate Cancer Research Centre, London. He was appointed as a consultant urologist to the former Middlesex Hospital in London in 2003, and prior to that was a consultant urologist at Nottingham City Hospital from 2000 where he was also director of postgraduate education.

Prior training included a two-year clinical post-doctoral fellowship in urological oncology, at the James Buchanan Brady Urological Institute, Johns Hopkins Hospital, Baltimore, Maryland, USA (1998-2000), and higher urological training at St Bartholomew’s and Royal London Hospitals (1992-1998). He qualified from University of Cambridge in 1987 and was awarded an MD degree for a thesis on Detection and Assessment of Early Prostate Cancer in 1996 and Hunterian Professorship at the Royal College of Surgeons of England in 1997.

He has published extensively in textbooks and peer-reviewed journals and led clinical research in many aspects of urology.